Page last updated: 2024-09-03

glycerophosphoinositol 4,5-bisphosphate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

glycerophosphoinositol 4,5-bisphosphate has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balla, T; Bojjireddy, N; Botyanszki, J; Brown, R; Creech, D; Hammond, G; Harrison, S; Kemp, DC; Moore, C; Morrison, A; Peterson, R; Snead, M; Wilson, S1

Other Studies

1 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate levels.
    The Journal of biological chemistry, 2014, Feb-28, Volume: 289, Issue:9

    Topics: Animals; Cell Membrane; Chlorocebus aethiops; COS Cells; Enzyme Activation; Gene Targeting; HEK293 Cells; Hepatitis C; Humans; Mice; Mice, Transgenic; Minor Histocompatibility Antigens; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphotransferases (Alcohol Group Acceptor); Type C Phospholipases

2014